Found: 67
Select item for more details and to access through your institution.
T cells engineered with a T cell receptor against the prostate antigen TARP specifically kill HLA-A2<sup>+</sup> prostate and breast cancer cells.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 149
- By:
- Publication type:
- Article
ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4<sup>+</sup> T cells.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 148
- By:
- Publication type:
- Article
Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 146
- By:
- Publication type:
- Article
Host epithelial geometry regulates breast cancer cell invasiveness.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 145
- By:
- Publication type:
- Article
Comprehensive molecular portraits of human breast tumours.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 144
- By:
- Publication type:
- Article
Estrogen receptor prevents p53-dependent apoptosis in breast cancer.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 143
- By:
- Publication type:
- Article
Prognostic Factors and Staging.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 1, p. 17
- By:
- Publication type:
- Article
Treatment - Metastatic and Advanced Disease.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 1, p. 34
- By:
- Publication type:
- Article
Treatment - Complications.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 1, p. 32
- By:
- Publication type:
- Article
Treatment - Radiotherapy.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 1, p. 31
- By:
- Publication type:
- Article
Treatment - Neoadjuvant and Adjuvant Therapy.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 1, p. 26
- By:
- Publication type:
- Article
Screening.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 1, p. 15
- By:
- Publication type:
- Article
Risk - Primary Disease.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 1, p. 15
- By:
- Publication type:
- Article
Biology - Disease.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 1, p. 9
- By:
- Publication type:
- Article
Prognostic Factors and Staging.
- Published in:
- Current Medical Literature: Breast Cancer, 2011, v. 23, n. 3, p. 102
- By:
- Publication type:
- Article
Treatment -- Neoadjuvant and Adjuvant Therapy.
- Published in:
- Current Medical Literature: Breast Cancer, 2011, v. 23, n. 3, p. 109
- By:
- Publication type:
- Article
Treatment -- Surgery.
- Published in:
- Current Medical Literature: Breast Cancer, 2011, v. 23, n. 3, p. 108
- By:
- Publication type:
- Article
Treatment -- Prevention.
- Published in:
- Current Medical Literature: Breast Cancer, 2011, v. 23, n. 3, p. 106
- By:
- Publication type:
- Article
Imaging.
- Published in:
- Current Medical Literature: Breast Cancer, 2011, v. 23, n. 3, p. 101
- By:
- Publication type:
- Article
Screening.
- Published in:
- Current Medical Literature: Breast Cancer, 2011, v. 23, n. 3, p. 100
- By:
- Publication type:
- Article
Risk -- Primary Disease.
- Published in:
- Current Medical Literature: Breast Cancer, 2011, v. 23, n. 3, p. 97
- By:
- Publication type:
- Article
Biology -- Therapy.
- Published in:
- Current Medical Literature: Breast Cancer, 2011, v. 23, n. 3, p. 95
- By:
- Publication type:
- Article
Biology -- Disease.
- Published in:
- Current Medical Literature: Breast Cancer, 2011, v. 23, n. 3, p. 89
- By:
- Publication type:
- Article
Targeting DNGR-1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas.
- Published in:
- European Journal of Immunology, 2014, v. 44, n. 7, p. 1947, doi. 10.1002/eji.201344076
- By:
- Publication type:
- Article
The Polymorphic Epithelial Mucin as a Target for Immunotherapya.
- Published in:
- Annals of the New York Academy of Sciences, 1993, v. 690, n. 1, p. 69, doi. 10.1111/j.1749-6632.1993.tb43997.x
- By:
- Publication type:
- Article
Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma.
- Published in:
- International Journal of Cancer, 1998, v. 79, n. 4, p. 402, doi. 10.1002/(SICI)1097-0215(19980821)79:4<402::AID-IJC16>3.0.CO;2-6
- By:
- Publication type:
- Article
Intramuscular immunisation with MUC1 cDNA can protect C57 mice challenged with MUC1-expressing syngeneic mouse tumour cells.
- Published in:
- International Journal of Cancer, 1996, v. 65, n. 5, p. 664, doi. 10.1002/(SICI)1097-0215(19960301)65:5<664::AID-IJC17>3.0.CO;2-7
- By:
- Publication type:
- Article
A short sequence, within the amino acid tandem repeat of a cancer-associated mucin, contains immunodominant epitopes.
- Published in:
- International Journal of Cancer, 1989, v. 44, n. 4, p. 691, doi. 10.1002/ijc.2910440423
- By:
- Publication type:
- Article
A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas.
- Published in:
- International Journal of Cancer, 1989, v. 43, n. 6, p. 1072, doi. 10.1002/ijc.2910430620
- By:
- Publication type:
- Article
Immunological analysis of mucin molecules expressed by normal and malignant mammary epithelial cells.
- Published in:
- International Journal of Cancer, 1987, v. 40, n. 3, p. 319, doi. 10.1002/ijc.2910400307
- By:
- Publication type:
- Article
The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0125994
- By:
- Publication type:
- Article
Transforming growth factor-β1 is constitutively secreted by chinese hamster ovary cells and is functional in human cells.
- Published in:
- Biotechnology & Bioengineering, 2011, v. 108, n. 11, p. 2759, doi. 10.1002/bit.23217
- By:
- Publication type:
- Article
Radioimmunoscintigraphy Using Monoclonal Antibodies before Second-Look Surgery in Patients Suffering from Ovarian Cancer.
- Published in:
- Gynecologic & Obstetric Investigation, 1987, v. 24, n. 3, p. 212, doi. 10.1159/000298805
- By:
- Publication type:
- Article
An α2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas.
- Published in:
- Glycobiology, 1999, v. 9, n. 12, p. 1307, doi. 10.1093/glycob/9.12.1307
- By:
- Publication type:
- Article
Cancer-associated hypersialylated MUC1 drives the differentiation of human monocytes into macrophages with a pathogenic phenotype.
- Published in:
- Communications Biology, 2020, v. 3, n. 1, p. N.PAG, doi. 10.1038/s42003-020-01359-5
- By:
- Publication type:
- Article
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.
- Published in:
- Breast Cancer Research, 2013, v. 15, n. 5, p. 1, doi. 10.1186/bcr3493
- By:
- Publication type:
- Article
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis.
- Published in:
- Breast Cancer Research, 2011, v. 13, n. 1, p. 1, doi. 10.1186/bcr2841
- By:
- Publication type:
- Article
Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation.
- Published in:
- Journal of Cellular & Molecular Medicine, 2012, v. 16, n. 7, p. 1474, doi. 10.1111/j.1582-4934.2011.01436.x
- By:
- Publication type:
- Article
Breast cancer associated transcriptional repressor PLU-1/JARID1B interacts directly with histone deacetylases.
- Published in:
- International Journal of Cancer, 2007, v. 121, n. 2, p. 265, doi. 10.1002/ijc.22673
- By:
- Publication type:
- Article
Responses of human T cells to peptides flanking the tandem repeat and overlapping the signal sequence of MUC1.
- Published in:
- International Journal of Cancer, 2005, v. 115, n. 5, p. 760, doi. 10.1002/ijc.20949
- By:
- Publication type:
- Article
Protection against MUC1 expressing mouse tumours by intra-muscular injection of MUC1 cDNA requires functional CD8.
- Published in:
- International Journal of Cancer, 2004, v. 109, n. 5, p. 691, doi. 10.1002/ijc.20040
- By:
- Publication type:
- Article
PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: A new cancer/testis antigen?
- Published in:
- International Journal of Cancer, 2002, v. 101, n. 6, p. 581, doi. 10.1002/ijc.10644
- By:
- Publication type:
- Article
Form and pattern of MUC1 expression on T cells activated in vivo orin vitro suggests a function in T-cell migration.
- Published in:
- Immunology, 2003, v. 108, n. 1, p. 32, doi. 10.1046/j.1365-2567.2003.01562.x
- By:
- Publication type:
- Article
KDM5B protein expressed in viable and fertile ΔARID mice exhibit no demethylase activity.
- Published in:
- International Journal of Oncology, 2021, v. 59, n. 5, p. N.PAG, doi. 10.3892/ijo.2021.5276
- By:
- Publication type:
- Article
Cancer-associated autoantibodies to MUC1 and MUC4-A blinded case-control study of colorectal cancer in UK collaborative trial of ovarian cancer screening.
- Published in:
- International Journal of Cancer, 2014, v. 134, n. 9, p. 2180, doi. 10.1002/ijc.28538
- By:
- Publication type:
- Article
T cells reactive with HLA-A*0201 peptides from the histone demethylase JARID1B are found in the circulation of breast cancer patients.
- Published in:
- International Journal of Cancer, 2011, v. 128, n. 9, p. 2114, doi. 10.1002/ijc.25792
- By:
- Publication type:
- Article
Selection of a Relevant In Vitro Blood-Brain Barrier Model to Investigate Pro-Metastatic Features of Human Breast Cancer Cell Lines.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0151155
- By:
- Publication type:
- Article
A mucin degrader for cancer therapy.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 4, p. 572, doi. 10.1038/s41587-023-01984-5
- By:
- Publication type:
- Article